MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

Model Number	TRF-605
Medical Device Problem Codes	Material Rupture (1546); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Seroma (2069)
Date of Event	03/15/2017
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Allergan did not submit this mdr within 30 days of becoming aware.Recent stimulated reporting related to 2011068-7/2/19-001-r has increased complaint and mdr volume.Allergan is implementing a plan to address the increased volumes.A review of the device history record has been completed.No deviations or non-conformances noted.The event of seroma is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: seroma-late.
Event or Problem Description
Patient reported left side "hardening".In addition patient reported "had a fluid collection on the left breast." device remains implanted.
Additional Manufacturer Narrative
Reason for reoperation: rupture.
Event or Problem Description
Healthcare professional later reported rupture.The device has been explanted.
Additional Manufacturer Narrative
Device evaluation: the device related to the reported event of rupture, seroma-late, visibility/palpability and anxiety¿product/procedure was received on (b)(6) 2023 with lot number 2978588.Based on the device analysis grid, the assessments of the complaint are: rupture: observed, one opening on radius side assessed as fold flaw opening, broken device on anterior side assessed as surgical damage and missing shell assessed as inconclusive.Visibility/palpability: unable to observe since it is not related to the device.Seroma-late: unable to observe since it is not related to the device.Anxiety¿product/procedure: unable to observe since it is not related to the device.Additional observations: creases are observed.Wear abrasion is observed.Nick is observed assessed as non-penetrating nick.Stress marks are observed assessed as non-penetrating nick.No further actions are required since no issue in the manufacturing of the device is observed.
Event or Problem Description
Patient reported left side "hardening".In addition patient reported "had a fluid collection on the left breast." later reported "bilateral rupture".Device has been explanted.

• Brand Name: INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT
• Common Device Name: PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
• Manufacturer (Section D): ALLERGAN (COSTA RICA); 900 parkway global park; zona franca; CS
• Manufacturer (Section G): ALLERGAN (COSTA RICA); 900 parkway global park; zona franca; CS
• Manufacturer Contact: terry ingram ; 12331-a riata trace parkway; building 3; austin, TX 78727 ; 8479366324
• MDR Report Key: 9889589
• Report Number: 9617229-2020-04583
• Device Sequence Number: 16656817
• Product Code: FTR
• UDI-Device Identifier: 10888628008380
• UDI-Public: 10888628008380
• Combination Product (Y/N): N
• PMA/510(K) Number: P020056
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2016
• Device Explanted Year: 2023
• Reporter Type: Manufacturer
• Report Source: Health Professional,Company Representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 10/23/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 09/24/2021
• Device Model Number: TRF-605
• Device Catalogue Number: TRF-605
• Device Lot Number: 2978588
• Was Device Available for Evaluation?: Device Returned to Manufacturer
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/30/2019
• Supplement Date Received by Manufacturer: 08/14/2023; 10/02/2023
• Initial Report FDA Received Date: 03/27/2020
• Supplement Report FDA Received Date: 09/05/2023; 10/23/2023
• Was Device Evaluated by Manufacturer? (Y/N): Yes
• Date Device Manufactured: 10/24/2016
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 32 YR
• Patient Sex: Female
• Patient Weight: 76 KG